
Home » InDevR Gains Market Clearance for Influenza A+B Assay
InDevR Gains Market Clearance for Influenza A+B Assay

May 10, 2019
The FDA granted InDevR 510(k) clearance for its FluChip-8G influenza diagnostic test, an assay that can identify multiple non-seasonal viruses.
The in vitro diagnostic test qualitatively detects and distinguishes between several influenza A viruses and the genetic lineage of influenza B viruses.
The single multiplexed assay can both characterize a variety of viruses as non-seasonal and characterize seasonal viruses in one day.
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr